Enhanced stability of the SARS CoV-2 spike glycoprotein following modification of an alanine cavity in the protein core.
Poumbourios P, Langer C, Boo I, Zakir T, Center RJ, Akerman A, Milogiannakis V, Aggarwal A, Johnstone BA, Ha J, Coulibaly F, Turville SG, Drummer HE
COVID-19
A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice.
Donnison T, McGregor J, Chinnakannan S, Hutchings C, Center RJ, Poumbourios P, Klenerman P, Drummer HE, Barnes E
Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs.
McGregor J, Hardy JM, Lay CS, Boo I, Piontek M, Suckow M, Coulibaly F, Poumbourios P, Center RJ, Drummer HE
Differential expression of HIV envelope epitopes on the surface of HIV-Infected macrophages and CD4<sup>+</sup> T cells.
Kek H, Laumaea A, Parise S, Poumbourios P, Hearps AC, Jaworowski A
Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine.
Center RJ, Boo I, Phu L, McGregor J, Poumbourios P, Drummer HE
Infectious KoRV-related retroviruses circulating in Australian bats.
Hayward JA, Tachedjian M, Kohl C, Johnson A, Dearnley M, Jesaveluk B, Langer C, Solymosi PD, Hille G, Nitsche A, Sánchez CA, Werner A, Kontos D, Crameri G, Marsh GA, Baker ML, Poumbourios P, Drummer HE, Holmes EC, Wang LF, Smith I, Tachedjian G
COVID-19